Anti-IgLON5 disease–the current state of knowledge and further perspectives
N Madetko, W Marzec, A Kowalska… - Frontiers in …, 2022 - frontiersin.org
Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in
2014. So far, less than 70 articles on this topic have been published. Due to its unspecific …
2014. So far, less than 70 articles on this topic have been published. Due to its unspecific …
Tauopathy and movement disorders—unveiling the chameleons and mimics
The spectrum of tauopathy encompasses heterogenous group of neurodegenerative
disorders characterized by neural or glial deposition of pathological protein tau. Clinically …
disorders characterized by neural or glial deposition of pathological protein tau. Clinically …
Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis
F Ye, C Fan, M Peng, S Liu, Y Yu, L Yang - Clinica Chimica Acta, 2021 - Elsevier
Abstract Introduction Anti-IgLON5 disease is a rare autoimmune disease of the central
nervous system. Different from the previous autoimmune encephalitis, the disease is a …
nervous system. Different from the previous autoimmune encephalitis, the disease is a …
[HTML][HTML] Head Drop and Trunk Flexion as an Early Manifestation of Anti‐IgLON5 Disease
KS Pillai, BV Maramattom, SG Santhamma… - Movement Disorders …, 2023 - ncbi.nlm.nih.gov
Discussion Anti-IgLON5 disease is a rare disease with an unclear pathophysiology and
overlapping features of neuroinflammation and neurodegeneration with tau accumulation. 3 …
overlapping features of neuroinflammation and neurodegeneration with tau accumulation. 3 …
[引用][C] Unusual Head Drops, Neck and Truncal Dystonia and Sleep Orthopnea with a Favorable Treatment Response in IgLon5 Antibody Disease.
K Bavdhankar, N Jain, S Agrawal… - Movement Disorders …, 2024 - europepmc.org
Unusual Head Drops, Neck and Truncal Dystonia and Sleep Orthopnea with a Favorable
Treatment Response in IgLon5 Antibody Disease. - Abstract - Europe PMC Sign in | Create an …
Treatment Response in IgLon5 Antibody Disease. - Abstract - Europe PMC Sign in | Create an …